Seranti Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.16 M
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.72 M
- Satisfied Charges ₹ 1.85 M
- Revenue Growth 4.65%
- Profit Growth 12.05%
- Ebitda 264.29%
- Net Worth 4.85%
- Total Assets -0.41%
About Seranti Pharmaceuticals
Seranti Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 November 2010 and has a history of 14 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.16 M.
The company currently has active open charges totaling ₹4.72 M. The company has closed loans amounting to ₹1.85 M, as per Ministry of Corporate Affairs (MCA) records.
Ahuti Rautaray and Susanta Senapati serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233TG2010PTC071088
- Company No.
071088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Seranti Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ahuti Rautaray  | Managing Director | 04-Nov-2010 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Susanta Senapati | Director | 14-Dec-2020 | Current |
Financial Performance of Seranti Pharmaceuticals.
Seranti Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.65% increase. The company also saw a substantial improvement in profitability, with a 12.05% increase in profit. The company's net worth moved up by a moderate rise of 4.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seranti Pharmaceuticals?
In 2019, Seranti Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.72 M
₹1.85 M
Charges Breakdown by Lending Institutions
- Others : 0.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2022 | Others | ₹0.24 M | Open |
| 30 Apr 2022 | Others | ₹0.48 M | Open |
| 31 May 2016 | Others | ₹4.00 M | Open |
| 20 Aug 2014 | Syndicate Bank | ₹1.35 M | Satisfied |
| 05 Dec 2013 | Oriental Bank Of Commerce | ₹0.50 M | Satisfied |
How Many Employees Work at Seranti Pharmaceuticals?
Seranti Pharmaceuticals has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seranti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seranti Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
